{"url_path":"/sec/cik-0001178879/8-k/2026-04-27/item-1-02","section_key":"item-1-02","section_title":"Item 1.02 Termination of a Material Definitive Agreement.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-04-27","source_url":"https://www.sec.gov/Archives/edgar/data/1178879/0001140361-26-016968-index.html","accession_number":"0001140361-26-016968","cik":"0001178879","ticker":null,"issuer_name":"AMICUS THERAPEUTICS, INC.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1178879/0001140361-26-016968-index.html","primary_entity_key":"0001178879","primary_entity_name":"AMICUS THERAPEUTICS, INC."},"word_count":126,"has_tables":true,"body_markdown":"Item 1.02\n\nTermination of a Material Definitive Agreement.\n\nOn April 27, 2026, in connection with the Merger, the Company repaid in full all outstanding indebtedness and all other amounts due and payable and terminated all\ncommitments under that certain Loan Agreement, dated October 2, 2023, (as amended, restated, amended and restated, supplemented and otherwise modified from time to time prior to the Closing Date, the “Amicus\n\nCredit Agreement”), by and among the Company, each of its subsidiaries party thereto, as guarantors, Blackstone Alternative Credit Advisors LP, Blackstone Life Sciences Advisors L.L.C., certain lenders from time to time party thereto\nand Wilmington Trust, National Association, as agent for the lenders. Additionally, the guarantees and liens securing the indebtedness under the Amicus Credit Agreement were discharged and released."}